...
首页> 外文期刊>Journal of Ophthalmology >Three-Year Outcomes of Cross-Linking PLUS (Combined Cross-Linking with Femtosecond Laser Intracorneal Ring Segments Implantation) for Management of Keratoconus
【24h】

Three-Year Outcomes of Cross-Linking PLUS (Combined Cross-Linking with Femtosecond Laser Intracorneal Ring Segments Implantation) for Management of Keratoconus

机译:交联PLUS(飞秒激光角膜内环段植入联合交联)治疗圆锥角膜的三年结果

获取原文
           

摘要

Purpose. To analyze the results of three-year outcomes of combined epithelium-on cross-linking with femtosecond laser ICRS (cross-linking PLUS) for keratoconus management. Design. A retrospective multicenter clinical study. Methods. 43 eyes of 38 patients were subjected to preoperative and postoperative UCVA, BCVA, refraction, Pentacam pachymetry, and keratometry examinations at 3-, 6-, 12-, 24-, and 36-month follow-up period. Results. The preoperative and postoperative mean UCVA was 1.30 ± 0.48 (logMAR ± SD) and 0.82 ± 0.22 respectively. The preoperative and postoperative mean BCVA was 0.90 ± 0.40 and 0.60 ± 0.30, respectively. The preoperative and postoperative mean K average was 50.63 ± 0.87 (D ± SD) and 45.56 ± 0.98, respectively. The preoperative and postoperative mean pachymetry was 471 ± 92.36 (μm ± SD) and 423 ± 39.58, respectively. The preoperative and postoperative mean astigmatism was 7.55 ± 1.75 and 3.39 ± 1.26, respectively. One eye showed ICRS edge exposure while 6 eyes showed progression of keratoconus. Conclusion. CXL PLUS was proved to be a successful procedure to halt progression (mainly by CXL) and to correct the refractive status of the keratoconic eye (mainly by ICRS). CXL PLUS performed a synergistic action correcting and maintaining the correction of both myopic and astigmatic components of keratoconus.
机译:目的。分析飞秒激光ICRS(交联PLUS)联合上皮上交联治疗圆锥角膜的三年结果。设计。回顾性多中心临床研究。方法。 38例患者的43只眼在术后3个月,6个月,12个月,24个月和36个月接受了术前和术后UCVA,BCVA,验光,Pentacam测厚法和角膜曲率检查。结果。术前和术后平均UCVA分别为1.30±0.48(logMAR±SD)和0.82±0.22。术前和术后平均BCVA分别为0.90±0.40和0.60±0.30。术前和术后平均K平均值分别为50.63±0.87(D±SD)和45.56±0.98。术前和术后平均测厚仪分别为471±92.36(μm±SD)和423±39.58。术前和术后平均散光分别为7.55±1.75和3.39±1.26。一只眼显示出ICRS边缘暴露,而六只眼则显示圆锥角膜进展。结论。 CXL PLUS被证明是阻止进展(主要是通过CXL进行)并纠正圆锥角膜眼睛的屈光状态(主要是通过ICRS)的成功方法。 CXL PLUS采取了协同作用,纠正并维持了圆锥角膜近视和散光组件的矫正。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号